PRESS RELEASE published on 12/11/2024 at 16:26, 1 year 5 months ago Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research publishes update on Formycon AG with BUY rating and EUR 82.00 price target, highlighting decline in revenue and upcoming biosimilar launches First Berlin Equity Research BUY Rating Formycon AG EUR 82.00 Price Target Biosimilar Launches
BRIEF published on 12/09/2024 at 06:35, 1 year 5 months ago MS Pharma to Commercialize FYB202 in MENA MENA Region Formycon AG Biosimilars MS Pharma FYB202
BRIEF published on 12/09/2024 at 06:35, 1 year 5 months ago MS Pharma va commercialiser FYB202 dans la région MENA Formycon AG MS Pharma Région MENA FYB202 Biosimilaires
PRESS RELEASE published on 12/09/2024 at 06:30, 1 year 5 months ago MS Pharma becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region Formycon AG and MS Pharma sign licensing and supply agreement for the commercialization of FYB202/ustekinumab biosimilar in MENA region, expanding patient access to vital treatments MENA Region Formycon AG MS Pharma FYB202 Ustekinumab
BRIEF published on 12/05/2024 at 13:00, 1 year 5 months ago Formycon Joins the SDAX of the German Stock Exchange Market Strategy Biosimilars SDAX Formycon German Stock Exchange
BRIEF published on 12/05/2024 at 13:00, 1 year 5 months ago Formycon rejoint le SDAX de la Bourse allemande Stratégie De Marché SDAX Formycon Biosimilaires Bourse Allemande
PRESS RELEASE published on 12/05/2024 at 12:55, 1 year 5 months ago Formycon joins the SDAX of the German Stock Exchange Formycon AG joins the SDAX of the German Stock Exchange, enhancing share attractiveness and visibility in the capital market. Key milestone in the company's growth strategy Formycon AG Biosimilars Capital Market SDAX German Stock Exchange
BRIEF published on 11/28/2024 at 06:35, 1 year 5 months ago Formycon Reports Continued Growth in 2024 Nine-Month Results Financial Results Market Position FDA Approval Biosimilars Strategic Growth
BRIEF published on 11/28/2024 at 06:35, 1 year 5 months ago Formycon annonce une croissance continue de ses résultats sur neuf mois en 2024 Résultats Financiers Croissance Stratégique Approbation De La FDA Biosimilaires Positionnement Sur Le Marché
PRESS RELEASE published on 11/28/2024 at 06:30, 1 year 5 months ago Formycon reports nine-month results for 2024 and continues growth trajectory with further operational successes Formycon reports nine-month results for 2024 with operational successes and growth trajectory, including product approvals and new biosimilar candidates Biosimilars Growth Trajectory Formycon Nine-month Results Operational Successes
Published on 05/14/2026 at 17:10, 36 minutes ago Namibia Critical Metals Announces Results of Annual General Meeting of Shareholders and Issuance of Options
Published on 05/14/2026 at 15:10, 2 hours 36 minutes ago Banyan Provides Summary of 2025 Diamond Drill Program for the Flagship AurMac Project, Yukon, Canada
Published on 05/14/2026 at 15:00, 2 hours 46 minutes ago Karbon-X Explores Clean Cooking and Fish Smoking Climate Initiative Concept in Senegal
Published on 05/14/2026 at 15:00, 2 hours 46 minutes ago ACCESS Newswire Celebrates PRSSA Bateman Competition Success and the Next Generation of Communications Leaders
Published on 05/14/2026 at 14:50, 2 hours 56 minutes ago Germany's BGR Assesses NextSource Materials' Molo Graphite Mine as Part of Federal Critical Minerals Study
Published on 05/14/2026 at 17:05, 40 minutes ago YAS ISLAND TO BE HOME OF SPHERE ABU DHABI, A NEW GLOBAL ICON FOR IMMERSIVE ENTERTAINMENT
Published on 05/14/2026 at 16:55, 50 minutes ago CGTN: 'Constructive strategic stability': China, US eye new vision for ties
Published on 05/14/2026 at 16:15, 1 hour 30 minutes ago Fibank successfully closed a record-breaking international placement for a Bulgarian bank, raising a total of EUR 310 million across two bond issues
Published on 05/14/2026 at 14:55, 2 hours 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/14/2026 at 14:54, 2 hours 51 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/14/2026 at 09:03, 8 hours 43 minutes ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 23 hours 43 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 23 hours 46 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
